AstraZeneca Pulls Twitter Ads, Showing Risks Of Expansive Social Media Platforms
This article was originally published in The Pink Sheet Daily
Executive Summary
Company thought sponsored messages on AP’s feed were unbranded, but realized drug name showed up in expanded tweet. Did intricacies of the platform produce an inadvertent violation?